Covalon Technologies (Covalon Technologies) 3-Year Revenue Growth Rate : 27.10% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies 3-Year Revenue Growth Rate?

Covalon Technologies's Revenue per Share for the three months ended in Dec. 2023 was $0.14.

During the past 12 months, Covalon Technologies's average Revenue per Share Growth Rate was 32.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 27.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was -6.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Covalon Technologies was 46.30% per year. The lowest was -27.40% per year. And the median was 12.40% per year.

Competitive Comparison of Covalon Technologies's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Covalon Technologies's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Covalon Technologies's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's 3-Year Revenue Growth Rate falls into.

Covalon Technologies 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Covalon Technologies (OTCPK:CVALF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Covalon Technologies 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Covalon Technologies (Covalon Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

COV:Canada

Address

1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7

Website

https://www.covalon.com

Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.